Marathon Oil is a restructuring story and is cheap compared to fellow North American E&P players, said Thomas Forester, portfolio manager for the Forester Value Fund. Forester added that Marathon is still immensely profitable even with oil prices moderating. Forester is also bullish on Amgen, saying the biotech powerhouse has a full pipeline and is under less pressure from biologic competition than Wall Street originally predicted. Finally, Forester is positive on J.C. Penney, stating that the retailer has turned itself around and it’s stock does not have to move very far to become a tremendously profitable investment.

More from Video

Former U.S. Education Secretary: Voters Are to Blame for Struggling Schools

Former U.S. Education Secretary: Voters Are to Blame for Struggling Schools

Meet Blackbird, the New 'Uber of the Skies'

Meet Blackbird, the New 'Uber of the Skies'

Here's How to Trade Walmart, Nordstrom, Macy's and J.C. Penney After Earnings

Here's How to Trade Walmart, Nordstrom, Macy's and J.C. Penney After Earnings

Here's Why Stock Picking Is Especially Important in the Retail Sector

Here's Why Stock Picking Is Especially Important in the Retail Sector

Tip For Financial Advisors: Think Outside the Box

Tip For Financial Advisors: Think Outside the Box